Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
Zhan-Miao Yi,1–3 Cheng Wen,1,2 Ting Cai,4 Lu Xu,4 Xu-Li Zhong,5 Si-Yan Zhan,4,6 Suo-Di Zhai1,3 1Department of Pharmacy, Peking University Third Hospital, Beijing, China; 2Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University Healt...
Guardado en:
Autores principales: | Yi ZM, Wen C, Cai T, Xu L, Zhong XL, Zhan SY, Zhai SD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0bfb3a2437454669aac22f3797b95a0a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
por: Ja Un Moon, et al.
Publicado: (2021) -
Effects of Levetiracetam Compared to Valproate on Cognitive Functions of Patients with Epilepsy
por: El Sabaa RM, et al.
Publicado: (2020) -
Efficacy and Safety of Levetiracetam vs. Phenobarbital for Neonatal Seizures: A Systematic Review and Meta-Analysis
por: Meng-Yuan Qiao, et al.
Publicado: (2021) -
Response to Levetiracetam Treatment and Long-Term Follow-Up in Dogs With Reactive Seizures Due to Probable Exogenous Toxicity
por: Fabio Stabile, et al.
Publicado: (2021) -
A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy
por: Zhang LL, et al.
Publicado: (2018)